MYC and retinoblastoma: By using the ubiquitous CAG promotor, the stage- and tissue-specificity of MYC expression was over-ridden, providing an explanation for how c-MYC could drive the phenotype despite c-MYC mutations not being common in retinoblastoma [23, 25, 50].